FAVOINO, ELVIRA
 Distribuzione geografica
Continente #
NA - Nord America 315
EU - Europa 141
AS - Asia 48
AF - Africa 4
SA - Sud America 1
Totale 509
Nazione #
US - Stati Uniti d'America 314
IT - Italia 78
GB - Regno Unito 20
FR - Francia 14
JP - Giappone 12
VN - Vietnam 12
IL - Israele 9
DE - Germania 8
AT - Austria 4
HK - Hong Kong 4
IR - Iran 4
SE - Svezia 4
UA - Ucraina 4
FI - Finlandia 3
IN - India 3
ES - Italia 2
IE - Irlanda 2
ZA - Sudafrica 2
AE - Emirati Arabi Uniti 1
BR - Brasile 1
CA - Canada 1
CN - Cina 1
DK - Danimarca 1
EG - Egitto 1
LY - Libia 1
NL - Olanda 1
TH - Thailandia 1
TW - Taiwan 1
Totale 509
Città #
Bari 34
Ashburn 29
Fairfield 27
Seattle 13
Dong Ket 12
Buffalo 9
Chicago 9
Leeds 9
Los Angeles 9
Boardman 8
Fleming Island 8
Tel Aviv 8
Davoli 7
Noicattaro 7
Tokyo 7
Bologna 6
Cambridge 5
Houston 5
London 5
Dallas 4
Lecce 4
New York 4
San Francisco 4
Southampton 4
Stockholm 4
Wilmington 4
Woodbridge 4
Ann Arbor 3
Atlanta 3
Cedar Knolls 3
Clearwater 3
Delhi 3
Helsinki 3
Bisceglie 2
Borgomanero 2
Chiyoda-ku 2
Columbus 2
Esslingen am Neckar 2
Federal Way 2
Las Vegas 2
Ma On Shan 2
Madrid 2
Milan 2
Nuremberg 2
Paris 2
Phoenix 2
San Diego 2
San Jose 2
Shatin 2
Silverton 2
Taranto 2
Toyosu 2
Tuam 2
Altamura 1
Barano d'Ischia 1
Brooklyn 1
Copenhagen 1
Council Bluffs 1
Crugers 1
Giza 1
Haifa 1
Herndon 1
Hillsboro 1
Indianapolis 1
Jacksonville 1
Kharkiv 1
Lake Forest 1
Leesburg 1
Louisville 1
Messina 1
Mottola 1
Naples 1
Omaha 1
Portland 1
Providence 1
Provo 1
Queens 1
Recife 1
Rochester 1
Scottsdale 1
Segrate 1
Sesto San Giovanni 1
Shanghai 1
Sheffield 1
Shibuya 1
Taipei 1
Toronto 1
Trang 1
Vienna 1
Totale 343
Nome #
Low mortality rate in Italian rheumatoid arthritis patients from a tertiary center: Putative implication of a low anti-carbamylated protein antibodies prevalence, file dd9e0c65-6bb6-1e9c-e053-3a05fe0a45ef 65
CD20-Mimotope Peptides: A Model to Define the Molecular Basis of Epitope Spreading, file dd9e0c66-c59f-1e9c-e053-3a05fe0a45ef 62
Subspecificities of anticentromeric protein A antibodies identify systemic sclerosis patients at higher risk of pulmonary vascular disease, file dd9e0c63-8693-1e9c-e053-3a05fe0a45ef 58
Anti-carbamylated protein antibodies and skin involvement in patients with systemic sclerosis: An intriguing association, file dd9e0c65-7677-1e9c-e053-3a05fe0a45ef 58
Clinical correlates of human leucocyte antigen (HLA)-G in systemic sclerosis, file dd9e0c62-eb35-1e9c-e053-3a05fe0a45ef 46
Why Do We Still Lack a COVID-19 Vaccine? Searching for the Missing Pieces, file 2e6fda2c-0814-4d68-ad2d-0f6a88967a46 45
HLA class I downregulation is associated with enhanced NK-cell killing of melanoma cells with acquired drug resistance to BRAF inhibitors, file dd9e0c6a-a500-1e9c-e053-3a05fe0a45ef 45
CD20 mimicry by a mAb rituximab-specific linear peptide: A potential tool for active immunotherapy of autoimmune diseases, file dd9e0c63-8d9c-1e9c-e053-3a05fe0a45ef 24
Antitumor activity of BRAF inhibitor and IFN×alpha; Combination in BRAF-mutant melanoma, file 34c0cace-4903-408e-8b52-630772a1dcf3 19
CD20: A target antigen for immunotherapy of autoimmune diseases, file dd9e0c63-8d9e-1e9c-e053-3a05fe0a45ef 19
Effects of Adjuvants for Human Use in Systemic Lupus Erythematosus (Sle)-Prone (Nzb/Nzw) F1 Mice, file dd9e0c62-5cef-1e9c-e053-3a05fe0a45ef 11
Two structurally different rituximab-specific CD20 mimotope peptides reveal that rituximab recognizes two different CD20-associated epitopes, file dd9e0c63-8989-1e9c-e053-3a05fe0a45ef 9
Chronic-Relapsing cutaneous leukocytoclastic vasculitis in a young patient with reduced EBV-specific T cell response using enzyme-linked immunospot (ELISPOT) assay successfully treated with Valaciclovir, file b10672fa-ed9a-4a45-8bc7-725f8b555770 5
Targeting cancer initiating cells in pancreatic adenocarcinoma, file dd9e0c63-84b8-1e9c-e053-3a05fe0a45ef 5
null, file dd9e0c6b-749e-1e9c-e053-3a05fe0a45ef 5
Circulating Irisin Levels in Patients with Chronic Plaque Psoriasis., file 212aa256-ece2-4b8e-bd73-f4ec14cf7ff5 4
Novel biomarker for pulmonary vascular disease in systemic sclerosis patients, file cd1aef79-c524-40a8-a6cb-1563ee9d01b9 4
Sars-cov-2 inflammatory syndrome. Clinical features and rationale for immunological treatment, file dd9e0c67-d40f-1e9c-e053-3a05fe0a45ef 4
Anti-centromere protein A antibodies in systemic sclerosis: Significance and origin, file dd9e0c62-e7b6-1e9c-e053-3a05fe0a45ef 3
Identification of an antigenic and immunogenic motif expressed by two 7-mer rituximab-specific cyclic peptide mimotopes: Implication for peptide-based active immunotherapy, file dd9e0c63-8988-1e9c-e053-3a05fe0a45ef 3
SARS-CoV-2 infection complicated by inflammatory syndrome. Could high-dose human immunoglobulin for intravenous use (IVIG) be beneficial?, file dd9e0c67-7e91-1e9c-e053-3a05fe0a45ef 3
Oxidized low density lipoproteins: The bridge between atherosclerosis and autoimmunity. Possible implications in accelerated atherosclerosis and for immune intervention in autoimmune rheumatic disorders., file dd9e0c64-ed2b-1e9c-e053-3a05fe0a45ef 2
null, file dd9e0c66-bfdc-1e9c-e053-3a05fe0a45ef 2
Dietary cholesterol supplementation and inhibitory factor 1 serum levels in two dizygotic Smith-Lemli-Opitz syndrome twins: a case report, file dd9e0c69-3938-1e9c-e053-3a05fe0a45ef 2
Anti-carbamylated protein antibodies in patients with systemic sclerosis: an intriguing association with skin involvement, file dd9e0c6a-dbde-1e9c-e053-3a05fe0a45ef 2
AB0695 Subspecificities of Anti-Centromeric-Associated Protein a (CENP-A) Antibodies (AB) Can Identified a Subset of Patients at Higher Risk of Developing Pulmonary Hypertension, file dd9e0c6a-feea-1e9c-e053-3a05fe0a45ef 2
null, file dd9e0c6b-2417-1e9c-e053-3a05fe0a45ef 2
 Peptides highly specific to the variable region of TNF-ALFA-specific references licensed (RL) monoclonal antibodies (MAB), as potential tool to effectively assess similarity between biosimilars and the correspondig RL MAB, file dd9e0c6b-3303-1e9c-e053-3a05fe0a45ef 2
Clinical correlates of a subset of anti-fibroblast antibodies in systemic sclerosis, file 0c592f01-2330-42ce-aca2-cadf85cfc23d 1
Systemic sclerosis and primary biliary cholangitis share an antibody population with identical specificity, file 16e3abf0-4a3c-4692-86f4-20354627ac0a 1
HLA allele prevalence in disease-modifying antirheumatic drugs-responsive enthesitis and/or arthritis not fulfilling ASAS criteria: Comparison with psoriatic and undifferentiated spondyloarthritis, file 6d6fb51a-2d81-4e20-85d8-ecdd75ee1aa2 1
β2-microglobulin-free HLA class I heavy chain epitope mimicry by monoclonal antibody HC-10-specific peptide, file 78c856e7-4b0f-4c2e-87b1-6768ff8993c4 1
null, file dd9e0c62-fa12-1e9c-e053-3a05fe0a45ef 1
Functional characterization of an scFv-Fc antibody that immunotherapeutically targets the common cancer cell surface proteoglycan CSPG4, file dd9e0c62-fb1f-1e9c-e053-3a05fe0a45ef 1
CD20-Mimotope Peptide Active Immunotherapy in Systemic Lupus Erythematosus and a Reappraisal of Vaccination Strategies in Rheumatic Diseases, file dd9e0c63-8e00-1e9c-e053-3a05fe0a45ef 1
Working and safety profiles of JAK/STAT signaling inhibitors. Are these small molecules also smart?, file dd9e0c6a-a9e9-1e9c-e053-3a05fe0a45ef 1
Totale 519
Categoria #
all - tutte 1.829
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 1.829


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202183 0 0 0 0 0 1 11 21 3 18 9 20
2021/2022127 8 10 2 5 6 4 13 7 2 5 43 22
2022/2023250 13 6 41 34 21 19 35 26 16 19 18 2
2023/202451 2 2 4 8 7 3 8 14 3 0 0 0
Totale 519